TABLE 2

Compositions of imidafenacin and its metabolites in plasma, urine, and feces after a single p.o. administration of 0.25 mg of [14C]imidafenacin in healthy male subjects

Numbers in parentheses denote percentage of total radioactivity in samples.


Metabolites

Mass Transition

Retention Time

Plasma

Urine

Feces
2 h
12 h
0-4 h
4-24 h
0-48 h
48-96 h
m/z min ng Eq/ml % dose
Imidafenacin 322→240 21.3-21.7 1.19 (33.3) 0.12 (10.7) 2.9 (14.2) 5.1 (13.9)
M-1 338→240 23.7 0.3 (1.4) 0.2 (0.5)
M-2 354→240 26.9-27.0 0.34 (9.5) 0.09 (7.6) 2.6 (13.0) 4.6 (12.4) 1.8 (9.9) 1.3 (10.9)
M-3 356→240 22.6-22.8 0.15 (4.1) 0.3 (1.3) 0.7 (1.9)
M-4 328→193 28.7-28.8 0.34 (9.4) 0.21 (18.0) 0.1 (0.5) 1.3 (3.6)
M-5 329→193 24.6-24.7 0.5 (2.6) 1.8 (5.0)
M-9 498→240 16.8-17.1 0.63 (17.6) 0.11 (9.9) 4.8 (23.6)a 9.1 (24.9)a
M-10 298→240 18.7-19.4 0.28 (7.9)b 0.7 (3.7) 0.7 (1.9) 1.0 (5.7) 0.6 (4.7)
HU2, HF2 (M-11a) 356→240 16.8-17.1 4.8 (23.6)a 9.1 (24.9)a 1.1 (6.2) 0.3 (2.8)
HP1, HU3, HF3 (M-11b) 356→240 18.3-18.9 0.28 (7.9)b 4.6 (22.6) 5.5 (14.9) 3.9 (21.9) 1.2 (9.7)
HU1 514→240 15.2-15.3 1.1 (5.6) 2.0 (5.4)
HF1 14.7-15.0 0.6 (3.3) 0.2 (1.4)
HF4 20.2-20.3 0.3 (1.7) 0.8 (6.4)
HF5 21.5 0.6 (3.3) 0.6 (4.8)
HF6 22.2 0.9 (5.1) 0.2 (1.9)
HF7 22.7-22.9 0.2 (0.9) 0.2 (1.5)
HF8 34.2-34.3 0.9 (4.8) 1.2 (9.5)
Others N.C. (2.7) N.C. (27.3) 2.3 (11.5) 5.7 (15.6) 6.6 (22.8) 5.7 (30.8)
Total


3.57 (84.5)
1.16 (73.5)
20.2 (100)
36.7 (100)
17.9 (85.6)
12.3 (84.4)
  • —, not detected; N.C., not calculated.

  • a Total amount of M-9 and HU2.

  • b Total amount of M-10 and HP1.